YAREMA KRISTIN (President, Cell Therapy) received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/12/2023ACC: 0001209191-23-024103
Officer· President, Cell Therapy
Since Apr 2023
+855.16K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
855.16K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+356.84K
Price / share
—
Trade value
—
% of position
New position
4/11/2023
0.00→356.84K
Total
Net shares
+356.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/11/2023 | A · Award | +356.84K | — | — | New position | 0.00 | 356.84K |
| Total | +356.84K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
498.32K shares
Shares
+498.32K
Strike price
2.62
Held after
498.32K
Exercisable
—
4/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock498.32K shares | 4/11/2023 | A · Award | +498.32K | 2.62 | — | 498.32K |